Search Results

You searched for : LatestPharmaNewsNov23

	PFIZER DOSES FIRST PARTICIPANT IN PHASE 3 STUDY EVALUATING ANTI-TFPI INVESTIGATIONAL THERAPY An anti-tissue factor pathway inhibitor being evaluated for the treatment of people with severe hemophilia A or B, with or without inhibitors.... Nov 23
	Merck Submits Applications for Licensure of V114, the Companyâ€™s Investigational 15-valent Pneumococcal Conjugate Vaccine ... Nov 23
	GSK starts phase 3 study of RSV maternal candidate vaccine Currently no vaccine is available for respiratory syncytial virus... Nov 23
	AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19 Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in ... Nov 23
	Acquisition adds to Merckâ€™s suite of clinical programs in response to SARS-CoV-2/COVID-19 Meaningful new therapeutic options are desperately needed for possibly millions of people around the world who will develop severe or critical COVID-19 disease... Nov 23
	European Commission approves MenQuadfi, the latest innovation in meningococcal vaccination The EC has approved MenQuadfi for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W and Y.... Nov 23
	Strides receives USFDA approval for Prednisone Tablets ... Nov 23
	Recently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure The oral antiviral medication Favipiravir, which prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with ... Nov 23
8 Matching result(s) found!

-Advertisements-

Trending Now
	Moscow Outpatient Departments to Implement AI X-ray InterpretationMay 31, 2024
	FLO launched Digital Ready Reckoner - of MSME schemes.May 31, 2024
	Candy flavoured traps to hook the next generationMay 31, 2024
	Software Engineering Research Centre (SERC) at IIIT H to host 21st Edition of IEEE International Conference on Software Architecture (ICSA) 2024May 31, 2024
	Federal Bank and Tata AIA Life Insurance Announce Strategic Bancassurance PartnershipMay 31, 2024
	Why Whole Spices are Better than Powdered: New ICMR GuidelinesMay 31, 2024
	Raising Awareness on Menstrual Health: NCW and SheWings Initiative on Menstrual Hygiene DayMay 31, 2024
	Innovative RNA Drugs Offer Hope for Patients with High CholesterolMay 31, 2024
	Advani Hotels & Resorts (India) Limited (Caravela Beach Resort, Goa)May 30, 2024
	FLO Hyderabad launches ‘Centre of Excellence for Training Women Vegetable Farming’May 30, 2024
	Should Doctors Be Exempt from the Consumer Protection Act? A Complex DebateMay 30, 2024
	Tamil Nadu Doctors Save 14-Year-Old Girl by Removing Needle from Lung with BronchoscopyMay 30, 2024
	The Lifesaving Journey of a Florist: Rare 'Bombay' Blood Group Donation Saves Life May 30, 2024
	The Impact of Heat on Eye Health: Preventing Eye Strokes During High TemperaturesMay 30, 2024
	Patients with super morbid obesity can find life-changing benefits beyond weight reduction through bariatric surgeryMay 29, 2024
	AI software could revolutionise voice box cancer treatmentMay 29, 2024
	Why You’re Waking Up to Pee: The Link Between Enlarged Prostate and NocturiaMay 29, 2024
	Rising Smoking Rates Among Teenage Girls: A Growing Health Crisis in IndiaMay 29, 2024
	WHO Launches $7 Billion Investment Round at the 77th World Health AssemblyMay 29, 2024
	From Insulin-Dependent to Insulin-Free in just 3 months: Game-Changing Diabetes Cure Developed by Chinese ScientistsMay 29, 2024

Search Results

PFIZER DOSES FIRST PARTICIPANT IN PHASE 3 STUDY EVALUATING ANTI-TFPI INVESTIGATIONAL THERAPY

Merck Submits Applications for Licensure of V114, the Companyâ€™s Investigational 15-valent Pneumococcal Conjugate Vaccine

GSK starts phase 3 study of RSV maternal candidate vaccine

AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19

Acquisition adds to Merckâ€™s suite of clinical programs in response to SARS-CoV-2/COVID-19

European Commission approves MenQuadfi, the latest innovation in meningococcal vaccination

Strides receives USFDA approval for Prednisone Tablets

Recently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure

Trending Now